台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide)
0.1.1 - ci-build
台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide) - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define data models that represent the domain covered by this implementation guide in more business-friendly terms than the underlying FHIR resources.
| 臺灣癌症登記長表邏輯模型 |
臺灣癌症登記長表邏輯模型 |
These define constraints on FHIR resources for systems conforming to this implementation guide.
These define constraints on FHIR data types for systems conforming to this implementation guide.
| Behavior Code(性態碼) |
病理診斷中的性態碼 |
| CTV-H(最高放射劑量) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受最高劑量 |
| CTV-L(較低放射劑量) |
記錄在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射線治療中接受次高劑量 |
| Dose to CTV_H(最高放射劑量臨床標靶體積劑量) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受最高劑量的目標區域之範圍的放射劑量 |
| Dose to CTV_L(較低放射劑量臨床標靶體積劑量) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射線治療中接受次高劑量的目標區域之範圍的放射劑量 |
| Dose to Other RT(其他放射治療臨床標靶體積劑量) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射線治療中接受特殊放射治療的目標區域之範圍的放射劑量 |
| Histology(組織型態) |
原發腫瘤細胞於顯微鏡下之結構 |
| Identifier Suffix |
識別碼後綴詞 |
| Last Contact or Death(最後連絡或死亡日期) |
個案的最後聯絡日期或是死亡日期 |
| Number of Fractions to CTV_H(最高放射劑量臨床標靶體積治療次數) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受最高劑量的目標區域之範圍的放射治療次數 |
| Number of Fractions to CTV_L(較低放射劑量臨床標靶體積治療次數) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受次高劑量的目標區域之範圍的放射治療次數 |
| Number of Fractions to Other RT(其他放射治療臨床標靶體積治療次數) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受特殊放射治療的目標區域之範圍的放射治療次數 |
| Other RT Technique(其他放射治療技術) |
在申報醫院的首次療程中，進行特殊放射治療所使用的技術 |
| Other RT(其他放射治療) |
在申報醫院的首次療程中，利用放射線涵蓋局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄特殊放射治療 |
| RT Status(放射治療執行狀態) |
在申報醫院的首次療程中，接受放射治療的執行狀態 |
| RT Target Summary(放射治療臨床標靶體積摘要) |
在申報醫院的首次療程中，進行放射治療之放射線標靶體積涵蓋的範圍 |
| Target of CTV_H(最高放射劑量臨床標靶體積) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射治療中接受最高劑量的目標區域之範圍 |
| Target of CTV_L(較低放射劑量臨床標靶體積) |
在申報醫院的首次療程中，利用放射線涵蓋之局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄體外射線治療中接受次高劑量的目標區域之範圍 |
| Target of Other RT(其他放射治療臨床標靶體積) |
在申報醫院的首次療程中，利用放射線涵蓋局部原發腫瘤(T)，區域淋巴結(N)或遠端轉移(M)來區分並記錄特殊放射治療的目標區域之範圍 |
These define sets of codes used by systems conforming to this implementation guide.
| AJCC 癌症分期版本與章節值集 |
The Edition and Chapter of AJCC Cancer Staging Value Set |
| SSF1 乳癌-動情激素接受體檢測(ERA)-Allred score值集 |
Estrogen Receptor Assay - Allred score Value Set |
| SSF1 乳癌-動情激素接受體檢測(ERA)-ER 反應比例值集 |
Estrogen Receptor Assay - ER Value Set |
| SSF1 乳癌-動情激素接受體檢測(ERA)值集 |
Estrogen Receptor Assay Value Set |
| SSF1 卵巢癌-療前 CA 125 檢驗值值集 |
Carbohydrate Antigen 125 (CA-125) : Lab Value Before Treatment Value Set |
| SSF1 子宮頸癌-SCC 抗原檢驗值值集 |
Serum Squamous Cell Carcinoma Antigen (SCC-Ag):Lab Value Value Set |
| SSF1 子宮體癌-動情激素接受體檢測(ERA)值集 |
Estrogen Receptor Assay Value Set |
| SSF1 攝護腺癌-攝護腺特異抗原指數值集 |
Prostatic Specific Antigen (PSA) Lab Value Value Set |
| SSF1 淋巴瘤-後天人類免疫不全病毒感染狀況的評估值集 |
Assessment status of HIV infection Value Set |
| SSF1 白血病-白血病染色體檢查的評估值集 |
Assessment of chromosome study in leukemia Value Set |
| SSF1 直腸乙狀結腸、直腸癌-癌胚抗原 CEA 檢驗值值集 |
Carcinoembryonic Antigen(CEA) Lab Value Value Set |
| SSF1 結腸癌-癌胚抗原 CEA 檢驗值值集 |
Site-Specific Factor 1 - colon Value Set |
| SSF1 肝癌-AFP 甲型胎兒蛋白檢驗值值集 |
Alpha-Fetoprotein(AFP) Lab Value Value Set |
| SSF1 肺癌-同側肺但非主病灶的另外肺腫瘤值集 |
Separate Tumor Nodules / Ipsilateral Lung Value Set |
| SSF1 胃癌-癌胚抗原 CEA 檢驗值值集 |
Carcinoembryonic Antigen(CEA) : Lab Value Value Set |
| SSF1 胰臟癌-癌胚抗原 CEA 檢驗值值集 |
Carcinoembryonic Antigen(CEA) Lab Value Value Set |
| SSF1 頭頸癌-被侵犯的頸部淋巴結的大小值集 |
Size of Lymph Nodes (Involved) Value Set |
| SSF10 乳癌-Ki-67值集 |
Ki-67 Value Set |
| SSF10 淋巴瘤-何杰金氏淋巴瘤預後因子 ESR 與 IPS值集 |
Prognostic factors of Hodgkin Lymphoma: ESR and IPS Value Set |
| SSF10 白血病-最近一次治療反應的微量殘餘疾病評估值集 |
Assessment of latest molecular treatment response Value Set |
| SSF10 直腸乙狀結腸、直腸癌-微星體不穩定檢測值集 |
Microsatellite Instability (MSI) Detection Value Set |
| SSF10 結腸癌-微星體不穩定檢測值集 |
Microsatellite Instability (MSI) Detection Value Set |
| SSF10 頭頸癌-病理淋巴結外侵犯狀態值集 |
Extranodal Extension (ENE) Pathological Value Set |
| SSF2 乳癌-黃體激素接受體檢測(PRA)-Allred score值集 |
Progesterone Receptor Assay - Allred score Value Set |
| SSF2 乳癌-黃體激素接受體檢測(PRA)-PR 反應比例值集 |
Progesterone Receptor Assay - PR Value Set |
| SSF2 乳癌-黃體激素接受體檢測(PRA)值集 |
Progesterone Receptor Assay Value Set |
| SSF2 卵巢癌-療後最低 CA 125 檢驗值值集 |
Carbohydrate Antigen 125 (CA-125) : Lab Value After Treatment Value Set |
| SSF2 子宮頸癌-SCC 抗原值集 |
Serum Squamous Cell Carcinoma Antigen (SCC-Ag) : Lab Value vs. Normal Value Value Set |
| SSF2 子宮體癌-黃體激素接受體檢測(PRA)值集 |
Progesterone Receptor Assay Value Set |
| SSF2 攝護腺癌-細針切片或經尿道攝護腺刮除檢體Gleason氏分級主要型態級數與次要型態級數值集 |
Gleason’s Primary Pattern and Secondary Pattern Value on Needle Core Biopsy/TURP Value Set |
| SSF2 淋巴瘤-診斷時全身性之症狀值集 |
Systemic symptoms at diagnosis Value Set |
| SSF2 白血病-白血病分子生物學檢查的評估值集 |
Assessment of molecular studies in leukemia Value Set |
| SSF2 直腸乙狀結腸、直腸癌-癌胚抗原 CEA 檢驗正常值值集 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Value Set |
| SSF2 結腸癌-癌胚抗原 CEA 檢驗正常值值集 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Value Set |
| SSF2 肝癌-肝纖維化的程度值集 |
Liver Fibrosis Score Value Set |
| SSF2 肺癌-波及臟層膜/彈性層值集 |
Visceral Pleural Invasion (VPI)/ Elastic Layer Value Set |
| SSF2 胃癌-癌胚抗原 CEA 檢驗正常值值集 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Value Set |
| SSF2 胰臟癌-癌胚抗原 CEA 檢驗正常值值集 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Value Set |
| SSF2 膀胱癌-區域淋巴結夾膜外侵犯情形值集 |
Extranodal(Extracapsular)Extension of Regional Lymph Nodes Value Set |
| SSF3 乳癌-前導性療法之療效值集 |
Response to Neoadjuvant Therapy Value Set |
| SSF3 卵巢癌-腫瘤手術後之殘存腫瘤狀態及大小值集 |
Residual Tumor Status and Size After Surgery Value Set |
| SSF3 攝護腺癌-細針切片或經尿道攝護腺刮除檢體Gleason氏分數值集 |
Gleason’s Score on Needle Core Biopsy/TURP Value Set |
| SSF3 淋巴瘤-IPI score 的評估值集 |
Assessment of International Prognostic Index score (IPI) Value Set |
| SSF3 直腸乙狀結腸、直腸癌-腫瘤縮小等級或分數值集 |
Tumor Regression Grade or Score Value Set |
| SSF3 結腸癌-腫瘤縮小等級或分數值集 |
Tumor Regression Grade or Score Value Set |
| SSF3 肝癌-Child Pugh 分數值集 |
Child Pugh Score Value Set |
| SSF3 胃癌-幽門螺旋桿菌值集 |
Helicobacter pylori Value Set |
| SSF3 胰臟癌-Carbohydrate Antigen 19-9值集 |
Carbohydrate Antigen 19-9 Value Set |
| SSF3 膀胱癌-固有肌肉層病理標本值集 |
Muscularis propria pathological samples Value Set |
| SSF3 頭頸癌-頸部第 I-III 區淋巴結侵犯範圍值集 |
Levels I-III, Lymph Nodes for Head and Neck Value Set |
| SSF3 食道癌-前導性療法後的病理反應值集 |
Tumor Regression Grade by pathology Value Set |
| SSF4 乳癌-哨兵淋巴結檢查數目值集 |
No. of Sentinel Lymph Nodes Examined Value Set |
| SSF4 攝護腺癌-攝護腺全切除或大體解剖檢體Gleason氏分級主要型態級數與次要型態級數值集 |
Gleason’s Primary Pattern and Secondary Pattern Value on Radical Prostatectomy Value Set |
| SSF4 淋巴瘤-FLIPI score 的評估值集 |
Assessment of Follicular Lymphoma International Prognostic Index score (FLIPI) Value Set |
| SSF4 直腸乙狀結腸、直腸癌-病理環切緣值集 |
Circumferential Resection Margin (CRM) Value Set |
| SSF4 結腸癌-病理環切緣值集 |
Circumferential Resection Margin (CRM) Value Set |
| SSF4 肝癌-肌酸(酐) 檢驗值值集 |
Creatinine (Cr) Value Value Set |
| SSF4 肺癌-惡性肋膜積水值集 |
Malignant Pleural Effusion Value Set |
| SSF4 胃癌-病理報告中的腫瘤深度值集 |
Measured Depth in Pathology Report Value Set |
| SSF4 胰臟癌-Ki-67值集 |
Ki-67 Value Set |
| SSF4 頭頸癌-頸部第 IV-V 區及後咽區淋巴結侵犯範圍值集 |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck Value Set |
| SSF4 食道癌-放射治療後的臨床反應值集 |
Tumor Regression Grade after Radiotherapy Value Set |
| SSF5 乳癌-哨兵淋巴結侵犯數目值集 |
No. of Sentinel Lymph Nodes Positive Value Set |
| SSF5 攝護腺癌-攝護腺全切除或解剖檢體 Gleason 氏分數值集 |
No. of Sentinel Lymph Nodes Positive Value Set |
| SSF5 直腸乙狀結腸、直腸癌-BRAF 基因突變值集 |
BRAF mutation detection Value Set |
| SSF5 結腸癌-BRAF 基因突變值集 |
BRAF mutation detection Value Set |
| SSF5 肝癌-總膽紅素檢驗值值集 |
Total bilirubin (Bil T) Value Value Set |
| SSF5 肺癌-縱膈腔淋巴結取樣或廓清值集 |
Sampling or Dissection of Mediastinal Lymph Nodes (N2 Nodes) Value Set |
| SSF5 胰臟癌-Mitotic Count值集 |
Mitotic Count Value Set |
| SSF5 頭頸癌-頸部第 VI-VII 區及顏面淋巴結侵犯範圍值集 |
Levels VI-VII and Facial Lymph Nodes for Head and Neck Value Set |
| SSF6 乳癌-Nottingham 或 BR 的分數/級數值集 |
Nottingham or Bloom-Richardson(BR) Score/Grade Value Set |
| SSF6 攝護腺癌-切片條數檢查數目值集 |
Nottingham or Bloom-Richardson(BR) Score/Grade Value Set |
| SSF6 白血病-巨細胞病毒感染狀況的評估值集 |
Assessment cytomegalovirus (CMV) infection condition Value Set |
| SSF6 直腸乙狀結腸、直腸癌-RAS 基因突變值集 |
RAS mutation detection Value Set |
| SSF6 結腸癌-RAS 基因突變值集 |
RAS mutation detection Value Set |
| SSF6 肝癌-凝血酶原時間國際正常比值值集 |
International Normalized Ratio for Prothrombin Time (INR) Value Set |
| SSF6 肺癌-EGFR 基因突變值集 |
EGFR (Epidermal growth factor receptor ) Gene Mutation Value Set |
| SSF6 頭頸癌-頸部側咽區,腮腺區,後枕或耳後區淋巴結侵犯範圍值集 |
Parapharyngeal, Parotid, and Suboccipital/ Retroauricular Lymph Nodes, Lymph Nodes for Head and Neck Value Set |
| SSF7 乳癌-HER2 免疫組織化學法的實驗數值值集 |
HER2 (Human Epidermal Growth Factor Receptor 2) IHC Test Lab Value Value Set |
| SSF7 攝護腺癌-切片條數陽性數目值集 |
Number of Cores Positive Value Set |
| SSF7 淋巴瘤-B 型肝炎表面抗原值集 |
HBsAg Value Set |
| SSF7 白血病-B 型肝炎表面抗原值集 |
HBsAg Value Set |
| SSF7 直腸乙狀結腸、直腸癌-腸阻塞值集 |
Obstruction Value Set |
| SSF7 結腸癌-腸阻塞值集 |
Obstruction Value Set |
| SSF7 肝癌-B 型肝炎表面抗原值集 |
HBsAg Value Set |
| SSF7 肺癌-ALK 基因轉位突變值集 |
ALK (Anaplastic lymphoma kinase) gene translocation Value Set |
| SSF7 頭頸癌-病理報告中的腫瘤深度值集 |
Measured Depth in Pathology Report Value Set |
| SSF8 淋巴瘤-C 型肝炎抗體值集 |
Anti-HCV Value Set |
| SSF8 白血病-C 型肝炎抗體值集 |
Anti-HCV Value Set |
| SSF8 直腸乙狀結腸、直腸癌-腸穿孔值集 |
Perforation Value Set |
| SSF8 結腸癌-腸穿孔值集 |
Perforation Value Set |
| SSF8 肝癌-C 型肝炎抗體值集 |
Anti-HCV Value Set |
| SSF8 肺癌-特定腺癌腫瘤組成值集 |
Specific component of lung adenocarcinoma Value Set |
| SSF9 淋巴瘤-急性肝炎發作的評估值集 |
Assessment status of acute hepatitis condition Value Set |
| SSF9 白血病-急性肝炎發作的評估值集 |
Assessment status of acute hepatitis condition Value Set |
| SSF9 直腸乙狀結腸、直腸癌-直腸腫瘤下緣與肛門口的距離值集 |
Rectal tumor distance from anus Value Set |
| SSF9 肺癌-腫瘤顆數值集 |
Tumor Nodules Value Set |
| SSF9 頭頸癌-臨床淋巴結外侵犯狀態值集 |
Extranodal Extension (ENE) Clinical Value Set |
| 個案分類值集 |
Class of Case Value Set |
| 側性值集 |
Laterality Value Set |
| 其他分期系統值集 |
Other Staging System Value Set |
| 其他分期系統期別(病理) |
Pathologic Other Staging Value Set |
| 其他分期系統期別(病理)-Breast Cancer |
Pathologic Other Staging - Breast Cancer Value Set |
| 其他分期系統期別(病理)-FIGO |
Pathologic Other Staging - FIGO Value Set |
| 其他分期系統期別(病理)-MAC |
Pathologic Other Staging - MAC Value Set |
| 其他分期系統期別(臨床) |
Clinical Other Staging Value Set |
| 其他分期系統期別(臨床) |
Clinical Other Staging - FIGO Value Set |
| 其他分期系統期別(臨床)-BCLC |
Clinical Other Staging - BCLC Value Set |
| 其他分期系統期別(臨床)-Breast Cancer |
Clinical Other Staging - Breast Cancer Value Set |
| 其他分期系統期別(臨床)-CLL |
Clinical Other Staging - CLL Value Set |
| 其他分期系統期別(臨床)-DRE |
Clinical Other Staging - DRE Value Set |
| 其他分期系統期別(臨床)-DSS |
Clinical Other Staging - DSS Value Set |
| 其他分期系統期別(臨床)-SCLC |
Clinical Other Staging - SCLC Value Set |
| 其他放射劑量臨床標靶體積值集 |
Target of Other RT Value Set |
| 其他放射劑量臨床標靶體積劑量值集 |
Dose to Other RT Value Set |
| 其他放射劑量臨床標靶體積治療次數值集 |
Number of Fractions to Other RT Value Set |
| 其他放射治療儀器值集 |
Other RT Modality Value Set |
| 其他放射治療技術-放射手術專用編碼值集 |
Other RT Technique 2 Value Set |
| 其他放射治療技術-放射線同位素治療專用編碼值集 |
Other RT Technique 4 Value Set |
| 其他放射治療技術-硼捉中子治療專用編碼值集 |
Other RT Technique 6 Value Set |
| 其他放射治療技術-質子或其他帶電荷粒子治療專用編碼值集 |
Other RT Technique 5 Value Set |
| 其他放射治療技術-近距放射治療專用編碼值集 |
Other RT Technique 3 Value Set |
| 其他放射治療技術-通用編碼值集 |
Other RT Technique 1 Value Set |
| 其他治療值集 |
Other Treatment Value Set |
| 區域治療與全身性治療順序值集 |
Sequence of Locoregional Therapy and Systemic Therapy Value Set |
| 區域淋巴結侵犯值集 |
Regional Lymph Nodes Positive Value Set |
| 區域淋巴結檢查值集 |
Regional Lymph Nodes Examined Value Set |
| 原發部位值集 |
Primary Site Value Set |
| 原發部位手術切緣距離值集 |
Surgical Margins Distance of the Primary Site Value Set |
| 原發部位手術邊緣值集 |
Surgical Margins of the Primary Site Value Set |
| 原發部位未手術原因值集 |
Reason for No Surgery of Primary Site Value Set |
| 吸菸年值集 |
Smoking Amount Value Set |
| 吸菸行為值集 |
Smoking Behavior Value Set |
| 喝酒行為值集 |
Drinking Behavior Value Set |
| 嚼檳榔年值集 |
Betel Nut Chewing Year Value Set |
| 嚼檳榔行為值集 |
Betel Nut Chewing Behavior Value Set |
| 外院免疫治療值集 |
Other Immunotherapy Value Set |
| 外院其他部位手術方式值集 |
Other Surgical Procedure Other Site Value Set |
| 外院化學治療值集 |
Other Chemotherapy Value Set |
| 外院區域淋巴結手術範圍值集 |
Other Scope of Regional LymphNode Surgery Value Set |
| 外院原發部位手術方式值集 |
Other Surgical Procedure of Primary Value Set |
| 外院標靶治療值集 |
Other Targeted Therapy Value Set |
| 外院荷爾蒙/類固醇值集 |
Other Hormone/Steroid Therapy Value Set |
| 外院診斷性及分期性手術處置值集 |
Other Surgical Diagnostic and Staging Profile Value Set |
| 微創手術值集 |
Minimally Invasive Surgery Value Set |
| 性態碼值集 |
Behavior Code Value Set |
| 戒嚼檳榔年值集 |
Betel Nut Chewing Quit Value Set |
| 戒菸年值集 |
Smoking Quit Value Set |
| 放射治療儀器值集 |
RT Modality Value Set |
| 放射治療執行狀態值集 |
RT Status Value Set |
| 放射治療臨床標靶體積摘要值集 |
RT Target Summary Value Set |
| 放射治療與手術順序值集 |
Sequence of Radiotherapy and Surgery Value Set |
| 最高放射劑量臨床標靶體積值集 |
Target of CTVH Value Set |
| 最高放射劑量臨床標靶體積劑量值集 |
Dose to CTVH Value Set |
| 最高放射劑量臨床標靶體積治療次數值集 |
Number of Fractions to CTVH Value Set |
| 每日吸菸量值集 |
Smoking Amount Value Set |
| 每日嚼檳榔量值集 |
Betel Nut Chewing Amount Value Set |
| 治療狀態分類值集 |
Class of Treatment Status Value Set |
| 淋巴管或血管侵犯值集 |
Lymph Vascular Invasion Value Set |
| 申報醫院免疫治療值集 |
Immunotherapy Value Set |
| 申報醫院其他部位手術方式值集 |
Surgical Procedure Other Site Value Set |
| 申報醫院化學治療值集 |
Chemotherapy Value Set |
| 申報醫院區域淋巴結手術範圍值集 |
Scope of Regional LymphNode Surgery Value Set |
| 申報醫院原發部位手術方式值集 |
Surgical Procedure of Primary Value Set |
| 申報醫院標靶治療值集 |
Targeted therapy Value Set |
| 申報醫院緩和照護值集 |
Palliative Care Value Set |
| 申報醫院荷爾蒙/類固醇值集 |
Hormone/Steroid Therapy Value Set |
| 申報醫院診斷性及分期性手術處置值集 |
Surgical Diagnostic and Staging Procedure Value Set |
| 病理 M 值集 |
Pathologic M Value Set |
| 病理 N 值集 |
Pathologic N Value Set |
| 病理 T 值集 |
Pathologic T Value Set |
| 病理分期字根/字首值集 |
Pathologic Stage (Prefix/Suffix) Descriptor Value Set |
| 病理分級/分化值集 |
Grade Pathological Value Set |
| 病理期別組合值集 |
Pathologic Stage Group Value Set |
| 癌症治療值集 |
Procedure Code Value Set |
| 癌症發生順序號碼值集 |
Sequence Number Value Set |
| 癌症確診方式值集 |
Diagnostic Confirmation Value Set |
| 相關行為值集 |
Observation Behavior Value Set |
| 神經侵襲值集 |
Perineural Invasion Value Set |
| 組織型態值集 |
Histology Value Set |
| 腫瘤大小值集 |
Tumor Size Value Set |
| 臨床 M 值集 |
Clinical M Value Set |
| 臨床 N 值集 |
Clinical N Value Set |
| 臨床 T 值集 |
Clinical T Value Set |
| 臨床分期字根/字首值集 |
Clinical Stage (Prefix/Suffix) Descriptor Value Set |
| 臨床分級/分化值集 |
Grade Clinical Value Set |
| 臨床期別組合值集 |
Clinical Stage Group Value Set |
| 診斷狀態分類值集 |
Class of Diagnosis Status Value Set |
| 身高值集 |
Height Value Set |
| 較低放射劑量臨床標靶體積值集 |
Target of CTVL Value Set |
| 較低放射劑量臨床標靶體積劑量值集 |
Dose to CTVL Value Set |
| 較低放射劑量臨床標靶體積治療次數值集 |
Number of Fractions to CTVL Value Set |
| 邏輯模型值集 |
Logical Model Value Set |
| 首次復發型式值集 |
Type of First Recurrence Value Set |
| 首次治療前生活功能狀態評估值集 |
Assessment Of Performance Status Before Treatment Value Set |
| 骨髓/幹細胞移植或內分泌處置值集 |
Hematologic Transplant and Endocrine Procedure Value Set |
| 體外放射治療技術值集 |
EBRT Technique Value Set |
| 體重值集 |
Weight Value Set |
These define new code systems used by systems conforming to this implementation guide.
| AJCC 癌症分期版本與章節代碼系統 |
The Edition and Chapter of AJCC Cancer Staging Code System |
| Other Targeted Therapy Code System |
Other Targeted Therapy Code System |
| SSF1 乳癌-動情激素接受體檢測(ERA)-Allred score代碼系統 |
Estrogen Receptor Assay - Allred score Code System |
| SSF1 乳癌-動情激素接受體檢測(ERA)-ER 反應比例代碼系統 |
Estrogen Receptor Assay - ER Code System |
| SSF1 乳癌-動情激素接受體檢測(ERA)代碼系統 |
Estrogen Receptor Assay Code System |
| SSF1 卵巢癌-療前 CA 125 檢驗值代碼系統 |
Carbohydrate Antigen 125 (CA-125) : Lab Value Before Treatment Code System |
| SSF1 子宮頸癌-SCC 抗原檢驗值代碼系統 |
Serum Squamous Cell Carcinoma Antigen (SCC-Ag):Lab Value Code System |
| SSF1 子宮體癌-動情激素接受體檢測(ERA)代碼系統 |
Estrogen Receptor Assay Code System |
| SSF1 攝護腺癌-攝護腺特異抗原指數代碼系統 |
Prostatic Specific Antigen (PSA) Lab Value Code System |
| SSF1 淋巴瘤-後天人類免疫不全病毒感染狀況的評估代碼系統 |
Assessment status of HIV infection Code System |
| SSF1 白血病-白血病染色體檢查的評估代碼系統 |
Assessment of chromosome study in leukemia Code System |
| SSF1 直腸乙狀結腸、直腸癌-癌胚抗原 CEA 檢驗值代碼系統 |
Carcinoembryonic Antigen(CEA) Lab Value Code System |
| SSF1 結腸癌-癌胚抗原 CEA 檢驗值代碼系統 |
Site-Specific Factor 1 - colon Code System |
| SSF1 肝癌-AFP 甲型胎兒蛋白檢驗值代碼系統 |
Alpha-Fetoprotein(AFP) Lab Value Code System |
| SSF1 肺癌-同側肺但非主病灶的另外肺腫瘤代碼系統 |
Separate Tumor Nodules / Ipsilateral Lung Code System |
| SSF1 胃癌-癌胚抗原 CEA 檢驗值代碼系統 |
Carcinoembryonic Antigen(CEA) : Lab Value Code System |
| SSF1 胰臟癌-癌胚抗原 CEA 檢驗值代碼系統 |
Carcinoembryonic Antigen(CEA) Lab Value Code System |
| SSF1 頭頸癌-被侵犯的頸部淋巴結的大小代碼系統 |
Size of Lymph Nodes (Involved) Code System |
| SSF10 乳癌-Ki-67代碼系統 |
Ki-67 Code System |
| SSF10 淋巴瘤-何杰金氏淋巴瘤預後因子 ESR 與 IPS代碼系統 |
Prognostic factors of Hodgkin Lymphoma: ESR and IPS Code System |
| SSF10 白血病-最近一次治療反應的微量殘餘疾病評估代碼系統 |
Assessment of latest molecular treatment response Code System |
| SSF10 直腸乙狀結腸、直腸癌-微星體不穩定檢測代碼系統 |
Microsatellite Instability (MSI) Detection Code System |
| SSF10 結腸癌-微星體不穩定檢測代碼系統 |
Microsatellite Instability (MSI) Detection Code System |
| SSF10 頭頸癌-病理淋巴結外侵犯狀態代碼系統 |
Extranodal Extension (ENE) Pathological Code System |
| SSF2 乳癌-黃體激素接受體檢測(PRA)-Allred score代碼系統 |
Progesterone Receptor Assay - Allred score Code System |
| SSF2 乳癌-黃體激素接受體檢測(PRA)-PR 反應比例代碼系統 |
Progesterone Receptor Assay - PR Code System |
| SSF2 乳癌-黃體激素接受體檢測(PRA)代碼系統 |
Progesterone Receptor Assay Code System |
| SSF2 卵巢癌-療後最低 CA 125 檢驗值代碼系統 |
Carbohydrate Antigen 125 (CA-125) : Lab Value After Treatment Code System |
| SSF2 子宮頸癌-SCC 抗原代碼系統 |
Serum Squamous Cell Carcinoma Antigen (SCC-Ag) : Lab Value vs. Normal Value Code System |
| SSF2 子宮體癌-黃體激素接受體檢測(PRA)代碼系統 |
Progesterone Receptor Assay Code System |
| SSF2 攝護腺癌-細針切片或經尿道攝護腺刮除檢體Gleason氏分級主要型態級數與次要型態級數 |
Gleason’s Primary Pattern and Secondary Pattern Value on Needle Core Biopsy/TURP Code System |
| SSF2 淋巴瘤-診斷時全身性之症狀代碼系統 |
Systemic symptoms at diagnosis Code System |
| SSF2 白血病-白血病分子生物學檢查的評估代碼系統 |
Assessment of molecular studies in leukemia Code System |
| SSF2 直腸乙狀結腸、直腸癌-癌胚抗原 CEA 檢驗正常值代碼系統 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Code System |
| SSF2 結腸癌-癌胚抗原 CEA 檢驗正常值代碼系統 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Code System |
| SSF2 肝癌-肝纖維化的程度代碼系統 |
Liver Fibrosis Score Code System |
| SSF2 肺癌-波及臟層膜/彈性層代碼系統 |
Visceral Pleural Invasion (VPI)/ Elastic Layer Code System |
| SSF2 胃癌-癌胚抗原 CEA 檢驗正常值代碼系統 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Code System |
| SSF2 胰臟癌-癌胚抗原 CEA 檢驗正常值代碼系統 |
Carcinoembryonic Antigen(CEA) : Lab Value vs. Normal Value Code System |
| SSF2 膀胱癌-區域淋巴結夾膜外侵犯情形代碼系統 |
Extranodal(Extracapsular)Extension of Regional Lymph Nodes Code System |
| SSF3 乳癌-前導性療法之療效代碼系統 |
Response to Neoadjuvant Therapy Code System |
| SSF3 卵巢癌-腫瘤手術後之殘存腫瘤狀態及大小代碼系統 |
Residual Tumor Status and Size After Surgery Code System |
| SSF3 攝護腺癌-細針切片或經尿道攝護腺刮除檢體Gleason氏分數代碼系統 |
Gleason’s Score on Needle Core Biopsy/TURP Code System |
| SSF3 淋巴瘤-IPI score 的評估代碼系統 |
Assessment of International Prognostic Index score (IPI) Code System |
| SSF3 直腸乙狀結腸、直腸癌-腫瘤縮小等級或分數代碼系統 |
Tumor Regression Grade or Score Code System |
| SSF3 結腸癌-腫瘤縮小等級或分數代碼系統 |
Tumor Regression Grade or Score Code System |
| SSF3 肝癌-Child Pugh 分數代碼系統 |
Child Pugh Score Code System |
| SSF3 胃癌-幽門螺旋桿菌代碼系統 |
Helicobacter pylori Code System |
| SSF3 胰臟癌-Carbohydrate Antigen 19-9代碼系統 |
Carbohydrate Antigen 19-9 Code System |
| SSF3 膀胱癌-固有肌肉層病理標本代碼系統 |
Muscularis propria pathological samples Code System |
| SSF3 頭頸癌-頸部第 I-III 區淋巴結侵犯範圍代碼系統 |
Levels I-III, Lymph Nodes for Head and Neck Code System |
| SSF3 食道癌-前導性療法後的病理反應代碼系統 |
Tumor Regression Grade by pathology Code System |
| SSF4 乳癌-哨兵淋巴結檢查數目代碼系統 |
No. of Sentinel Lymph Nodes Examined Code System |
| SSF4 攝護腺癌-攝護腺全切除或大體解剖檢體Gleason氏分級主要型態級數與次要型態級數代碼系統 |
Gleason’s Primary Pattern and Secondary Pattern Value on Radical Prostatectomy Code System |
| SSF4 淋巴瘤-FLIPI score 的評估代碼系統 |
Assessment of Follicular Lymphoma International Prognostic Index score (FLIPI) Code System |
| SSF4 直腸乙狀結腸、直腸癌-病理環切緣代碼系統 |
Circumferential Resection Margin (CRM) Code System |
| SSF4 結腸癌-病理環切緣深度代碼系統 |
Circumferential Resection Margin (CRM) Code System |
| SSF4 肝癌-肌酸(酐) 檢驗值代碼系統 |
Creatinine (Cr) Value Code System |
| SSF4 肺癌-惡性肋膜積水代碼系統 |
Malignant Pleural Effusion Code System |
| SSF4 胃癌-病理報告中的腫瘤深度代碼系統 |
Measured Depth in Pathology Report Code System |
| SSF4 胰臟癌-Ki-67代碼系統 |
Ki-67 Code System |
| SSF4 頭頸癌-頸部第 IV-V 區及後咽區淋巴結侵犯範圍代碼系統 |
Levels IV-V and Retropharyngeal Lymph Nodes for Head and Neck Code System |
| SSF4 食道癌-放射治療後的臨床反應代碼系統 |
Tumor Regression Grade after Radiotherapy Code System |
| SSF5 乳癌-哨兵淋巴結侵犯數目代碼系統 |
No. of Sentinel Lymph Nodes Positive Code System |
| SSF5 攝護腺癌-攝護腺全切除或解剖檢體 Gleason 氏分數代碼系統 |
No. of Sentinel Lymph Nodes Positive Code System |
| SSF5 直腸乙狀結腸、直腸癌-BRAF 基因突變代碼系統 |
BRAF mutation detection Code System |
| SSF5 結腸癌-BRAF 基因突變代碼系統 |
BRAF mutation detection Code System |
| SSF5 肝癌-總膽紅素檢驗值代碼系統 |
Total bilirubin (Bil T) Value Code System |
| SSF5 肺癌-縱膈腔淋巴結取樣或廓清代碼系統 |
Sampling or Dissection of Mediastinal Lymph Nodes (N2 Nodes) Code System |
| SSF5 胰臟癌-Mitotic Count代碼系統 |
Mitotic Count Code System |
| SSF5 頭頸癌-頸部第 VI-VII 區及顏面淋巴結侵犯範圍代碼系統 |
Levels VI-VII and Facial Lymph Nodes for Head and Neck Code System |
| SSF6 乳癌-Nottingham 或 BR 的分數/級數代碼系統 |
Nottingham or Bloom-Richardson(BR) Score/Grade Code System |
| SSF6 攝護腺癌-切片條數檢查數目代碼系統 |
Nottingham or Bloom-Richardson(BR) Score/Grade Code System |
| SSF6 白血病-巨細胞病毒感染狀況的評估代碼系統 |
Assessment cytomegalovirus (CMV) infection condition Code System |
| SSF6 直腸乙狀結腸、直腸癌-RAS 基因突變代碼系統 |
RAS mutation detection Code System |
| SSF6 結腸癌-RAS 基因突變代碼系統 |
RAS mutation detection Code System |
| SSF6 肝癌-凝血酶原時間國際正常比值代碼系統 |
International Normalized Ratio for Prothrombin Time (INR) Code System |
| SSF6 肺癌-EGFR 基因突變代碼系統 |
EGFR (Epidermal growth factor receptor ) Gene Mutation Code System |
| SSF6 頭頸癌-頸部側咽區,腮腺區,後枕或耳後區淋巴結侵犯範圍代碼系統 |
Parapharyngeal, Parotid, and Suboccipital/ Retroauricular Lymph Nodes, Lymph Nodes for Head and Neck Code System |
| SSF7 乳癌-HER2 免疫組織化學法的實驗數值代碼系統 |
HER2 (Human Epidermal Growth Factor Receptor 2) IHC Test Lab Value Code System |
| SSF7 攝護腺癌-切片條數陽性數目代碼系統 |
Number of Cores Positive Code System |
| SSF7 淋巴瘤-B 型肝炎表面抗原代碼系統 |
HBsAg Code System |
| SSF7 白血病-B 型肝炎表面抗原代碼系統 |
HBsAg Code System |
| SSF7 直腸乙狀結腸、直腸癌-腸阻塞代碼系統 |
Obstruction Code System |
| SSF7 結腸癌-腸阻塞代碼系統 |
Obstruction Code System |
| SSF7 肝癌-B 型肝炎表面抗原代碼系統 |
HBsAg Code System |
| SSF7 肺癌-ALK 基因轉位突變代碼系統 |
ALK (Anaplastic lymphoma kinase) gene translocation Code System |
| SSF7 頭頸癌-病理報告中的腫瘤深度代碼系統 |
Measured Depth in Pathology Report Code System |
| SSF8 淋巴瘤-C 型肝炎抗體代碼系統 |
Anti-HCV Code System |
| SSF8 白血病-C 型肝炎抗體代碼系統 |
Anti-HCV Code System |
| SSF8 直腸乙狀結腸、直腸癌-腸穿孔代碼系統 |
Perforation Code System |
| SSF8 結腸癌-腸穿孔代碼系統 |
Perforation Code System |
| SSF8 肝癌-C 型肝炎抗體代碼系統 |
Anti-HCV Code System |
| SSF8 肺癌-特定腺癌腫瘤組成代碼系統 |
Specific component of lung adenocarcinoma Code System |
| SSF9 淋巴瘤-急性肝炎發作的評估代碼系統 |
Assessment status of acute hepatitis condition Code System |
| SSF9 白血病-急性肝炎發作的評估代碼系統 |
Assessment status of acute hepatitis condition Code System |
| SSF9 直腸乙狀結腸、直腸癌-直腸腫瘤下緣與肛門口的距離代碼系統 |
Rectal tumor distance from anus Code System |
| SSF9 肺癌-腫瘤顆數代碼系統 |
Tumor Nodules Code System |
| SSF9 頭頸癌-臨床淋巴結外侵犯狀態代碼系統 |
Extranodal Extension (ENE) Clinical Code System |
| Surgical Margins Distance of the Primary Site Code System |
Surgical Margins Distance of the Primary Site Code System |
| 個案分類代碼系統 |
Class of Case Code System |
| 側性代碼系統 |
Laterality Code System |
| 其他分期系統代碼系統 |
Other Staging System Code System |
| 其他分期系統期別(病理)-Breast Cancer代碼系統 |
Pathologic Other Staging - Breast Cancer Code System |
| 其他分期系統期別(病理)-FIGO代碼系統 |
Pathologic Other Staging - FIGO Code System |
| 其他分期系統期別(病理)-MAC代碼系統 |
Pathologic Other Staging - MAC Code System |
| 其他分期系統期別(病理)代碼系統 |
Pathologic Other Staging Code System |
| 其他分期系統期別(臨床)-BCLC代碼系統 |
Clinical Other Staging - BCLC Code System |
| 其他分期系統期別(臨床)-Breast Cancer代碼系統 |
Clinical Other Staging - Breast Cancer Code System |
| 其他分期系統期別(臨床)-CLL代碼系統 |
Clinical Other Staging - CLL Code System |
| 其他分期系統期別(臨床)-DRE代碼系統 |
Clinical Other Staging - DRE Code System |
| 其他分期系統期別(臨床)-DSS代碼系統 |
Clinical Other Staging - DSS Code System |
| 其他分期系統期別(臨床)-SCLC代碼系統 |
Clinical Other Staging - SCLC Code System |
| 其他分期系統期別(臨床)代碼系統 |
Clinical Other Staging Code System |
| 其他分期系統期別(臨床)代碼系統 |
Clinical Other Staging - FIGO Code System |
| 其他放射劑量臨床標靶體積代碼系統 |
Target of Other RT Code System |
| 其他放射劑量臨床標靶體積劑量代碼系統 |
Dose to Other RT Code System |
| 其他放射劑量臨床標靶體積治療次數代碼系統 |
Number of Fractions to Other RT Code System |
| 其他放射治療儀器代碼系統 |
Other RT Modality Code System |
| 其他放射治療技術-放射線同位素治療專用編碼代碼系統 |
Other RT Technique 4 Code System |
| 其他放射治療技術-硼捉中子治療專用編碼代碼系統 |
Other RT Technique 6 Code System |
| 其他放射治療技術-質子或其他帶電荷粒子治療專用編碼代碼系統 |
Other RT Technique 5 Code System |
| 其他放射治療技術-近距放射治療專用編碼代碼系統 |
Other RT Technique 3 Code System |
| 其他放射治療技術-通用編碼代碼系統 |
Other RT Technique 1 Code System |
| 其他放射治療技術-通用編碼代碼系統 |
Other RT Technique 2 Code System |
| 其他治療代碼系統 |
Other Treatment Code System |
| 區域治療與全身性治療順序代碼系統 |
Sequence of Locoregional Therapy and Systemic Therapy Code System |
| 區域淋巴結侵犯代碼系統 |
Regional Lymph Nodes Positive Code System |
| 區域淋巴結檢查代碼系統 |
Regional Lymph Nodes Examined Code System |
| 原發部位代碼系統 |
Primary Site Code System |
| 原發部位手術邊緣代碼系統 |
Surgical Margins of the Primary Site Code System |
| 原發部位未手術原因代碼系統 |
Reason for No Surgery of Primary Site Code System |
| 吸菸年代碼系統 |
Smoking Year Code System |
| 吸菸行為代碼系統 |
Smoking Behavior Code System |
| 喝酒行為代碼系統 |
Drinking Behavior Code System |
| 嚼檳榔年代碼系統 |
Betel Nut Chewing Year Code System |
| 嚼檳榔行為代碼系統 |
Betel Nut Chewing Behavior Code System |
| 外院免疫治療代碼系統 |
Other Immunotherapy Code System |
| 外院其他部位手術方式代碼系統 |
Other Surgical Procedure Other Site Code System |
| 外院化學治療代碼系統 |
Other Chemotherapy Code System |
| 外院區域淋巴結手術範圍代碼系統 |
Other Scope of Regional Lymph Node Surgery Code System |
| 外院原發部位手術方式代碼系統 |
Other Surgical Procedure of Primary Code System |
| 外院荷爾蒙/類固醇代碼系統 |
Other Hormone/Steroid Therapy Code System |
| 外院診斷性及分期性手術處置代碼系統 |
Other Surgical Diagnostic and Staging Code System |
| 微創手術代碼系統 |
Minimally Invasive Surgery Code System |
| 性態碼代碼系統 |
Behavior Code Code System |
| 戒嚼檳榔年代碼系統 |
Betel Nut Chewing Quit Code System |
| 戒菸年代碼系統 |
Smoking Quit Code System |
| 放射治療儀器代碼系統 |
RT Modality Code System |
| 放射治療執行狀態代碼系統 |
RT Status Code System |
| 放射治療臨床標靶體積摘要代碼系統 |
RT Target Summary Code System |
| 放射治療與手術順序代碼系統 |
Sequence of Radiotherapy and Surgery Code System |
| 最高放射劑量臨床標靶體積代碼系統 |
Target of CTVH Code System |
| 最高放射劑量臨床標靶體積劑量代碼系統 |
Dose to CTVH Code System |
| 最高放射劑量臨床標靶體積治療次數代碼系統 |
Number of Fractions to CTVH Code System |
| 每日吸菸量代碼系統 |
Smoking Amount Code System |
| 每日嚼檳榔量代碼系統 |
Betel Nut Chewing Amount Code System |
| 治療狀態分類代碼系統 |
Class of Treatment Status Code System |
| 淋巴管或血管侵犯代碼系統 |
Lymph Vascular Invasion Code System |
| 申報醫院免疫治療代碼系統 |
Immunotherapy Code System |
| 申報醫院其他部位手術方式代碼系統 |
Surgical Procedure Other Site Code System |
| 申報醫院化學治療代碼系統 |
Chemotherapy Code System |
| 申報醫院區域淋巴結手術範圍代碼系統 |
Scope of Regional Lymph Node Surgery Code System |
| 申報醫院原發部位手術方式代碼系統 |
Surgical Procedure of Primary Code System |
| 申報醫院標靶治療代碼系統 |
Targeted Therapy Code System |
| 申報醫院緩和照護代碼系統 |
Palliative Care Code System |
| 申報醫院荷爾蒙/類固醇代碼系統 |
Hormone/Steroid Therapy Code System |
| 申報醫院診斷性及分期性手術處置代碼系統 |
Surgical Diagnostic and Staging Procedure Code System |
| 病理 M 代碼系統 |
Pathologic M Code System |
| 病理 N 代碼系統 |
Pathologic N Code System |
| 病理 T 代碼系統 |
Pathologic T Code System |
| 病理分期字根/字首代碼系統 |
Pathologic Stage (Prefix/Suffix) Descriptor Code System |
| 病理分級/分化代碼系統 |
Grade Pathological Code System |
| 病理期別組合代碼系統 |
Pathologic Stage Group Code System |
| 癌症治療代碼系統 |
Procedure Code Code System |
| 癌症發生順序號碼代碼系統 |
Sequence Number Code System |
| 癌症確診方式代碼系統 |
Diagnostic Confirmation Code System |
| 相關行為代碼系統 |
Observation Behavior Code System |
| 神經侵襲代碼系統 |
Perineural Invasion Code System |
| 組織型態代碼系統 |
Histology Code System |
| 腫瘤大小代碼系統 |
Tumor Size Code System |
| 臨床 M 代碼系統 |
Clinical M Code System |
| 臨床 N 代碼系統 |
Clinical N Code System |
| 臨床 T 代碼系統 |
Clinical T Code System |
| 臨床分期字根/字首代碼系統 |
Clinical Stage (Prefix/Suffix) Descriptor Code System |
| 臨床分級/分化代碼系統 |
Grade Clinical Code System |
| 臨床期別組合代碼系統 |
Clinical Stage Group Code System |
| 診斷狀態分類代碼系統 |
Class of Diagnosis Status Code System |
| 身高代碼系統 |
Height Code System |
| 較低放射劑量臨床標靶體積代碼系統 |
Target of CTVL Code System |
| 較低放射劑量臨床標靶體積劑量代碼系統 |
Dose to CTVL Code System |
| 較低放射劑量臨床標靶體積治療次數代碼系統 |
Number of Fractions to CTVL Code System |
| 邏輯模型代碼系統 |
Logical Model Code System |
| 首次復發型式代碼系統 |
Type of First Recurrence Code System |
| 首次治療前生活功能狀態評估代碼系統 |
Assessment Of Performance Status Before Treatment Code System |
| 骨髓/幹細胞移植或內分泌處置代碼系統 |
Hematologic Transplant and Endocrine Procedure Code System |
| 體外放射治療技術代碼系統 |
EBRT Technique Code System |
| 體重代碼系統 |
Weight Code System |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| LFAssOfPerStaBeforeTreatmentExample |
Example of Assessment Of Performance Status Before Treatment |
| LFBetNutChewBehExample |
Example of Betel Nut Chewing Behavior |
| LFBundleExample |
Example of Bundle |
| LFChemAtOthFacExample |
Example of Chemotherapy At Other Facility |
| LFChemExample |
Example of Chemotherapy |
| LFCliMExample |
Example of Clinical M |
| LFCliNExample |
Example of Clinical N |
| LFCliOthStagingExample |
Example of Clinical Other Staging |
| LFCliStageDesExample |
Example of Clinical Stage (Prefix/Suffix) Descriptor |
| LFCliStageExample |
Example of Clinical Stage |
| LFCliTExample |
Example of Clinical T |
| LFConditionExample |
Example of Condition |
| LFDateOfDiaConditionExample |
Example of Date Of Diagnosis Condition |
| LFDateOfFirMicroConfirmExample |
Example of Date of First Microscopic Confirmation |
| LFDriBehExample |
Example of Drinking Behavior |
| LFEBRTTechExample |
Example of EBRT Technique |
| LFEncounterExample |
Example of Encounter |
| LFFirCouOfTreatmentExample |
Example of First Course of Treatment |
| LFFirRecurExample |
Example of First Recurrence |
| LFFirSurProcExample |
Example of First Surgical Procedure |
| LFGradeCliExample |
Example of Grade Clinical |
| LFGradePathExample |
Example of Grade Pathological |
| LFHeightExample |
Example of Height |
| LFHemTransEndProcedureExample |
Example of Hematologic Transplant Endocrine Procedure |
| LFHorSteTherapyAtOthFacExample |
Example of Hormone Steroid Therapy At Other Facility |
| LFHorSteTherapyExample |
Example of Hormone Steroid Therapy |
| LFImmuAtOthFacExample |
Example of Immunotherapy At Other Facility |
| LFImmuExample |
Example of Immunotherapy |
| LFLymVasInvExample |
Example of Lymph Vascular Invasion |
| LFMiniInvSurExample |
Example of Minimally Invasive Surgery |
| LFOrganizationExample |
Example of Organization |
| LFOthRTExample |
Example of Other RT |
| LFOthTreatmentExample |
Example of Other Treatment |
| LFPalCareExample |
Example of Palliative Care |
| LFPathMExample |
Example of Pathologic M |
| LFPathNExample |
Example of Pathologic N |
| LFPathOthStagingExample |
Example of Pathologic Other Staging |
| LFPathStageDesExample |
Example of Pathologic Stage (Prefix/Suffix) Descriptor |
| LFPathStageExample |
Example of Pathologic Stage |
| LFPathTExample |
Example of Pathologic T |
| LFPatientExample |
Example of Patient |
| LFPerInvExample |
Example of Perineural Invasion |
| LFPractitionerExample |
Example of Practitioner |
| LFPrimaryCancerExample |
Example of Primary Cancer |
| LFRTExample |
Example of RT |
| LFReaForNoSurOfPriSiteExample |
Example of Reason for No Surgery of Primary Site |
| LFRegLymNodesExaExample |
Example of Regional Lymph Nodes Examined |
| LFRegLymNodesExaExample-1 |
Example of Regional Lymph Nodes Examined |
| LFRegLymNodesPosExample |
Example of Regional Lymph Nodes Positive |
| LFRegLymNodesPosExample-1 |
Example of Regional Lymph Nodes Positive |
| LFSSF10Example |
Example of Site-Specific Factor 10 |
| LFSSF1Example |
Example of Site-Specific Factor 1 |
| LFSSF2Example |
Example of Site-Specific Factor 2 |
| LFSSF3Example |
Example of Site-Specific Factor 3 |
| LFSSF4Example |
Example of Site-Specific Factor 4 |
| LFSSF5Example |
Example of Site-Specific Factor 5 |
| LFSSF6Example |
Example of Site-Specific Factor 6 |
| LFSSF7Example |
Example of Site-Specific Factor 7 |
| LFSSF8Example |
Example of Site-Specific Factor 8 |
| LFSSF9Example |
Example of Site-Specific Factor 9 |
| LFScoOfRegLymNodeSurAtOthFacExample |
Example of Scope of Regional Lymph Node Surgery at Other Facility |
| LFScoOfRegLymNodeSurExample |
Example of Scope of Regional Lymph Node Surgery |
| LFSeqOfLocTherAndSysTherExample |
Example of Sequence of Locoregional Therapy and Systemic Therapy |
| LFSeqOfRadAndSurExample |
Example of Sequence of Radiotherapy and Surgery |
| LFSmokBehExample |
Example of Smoking Behavior |
| LFSurDiaAndStagingProcAtOthFacExample |
Example of Surgical Diagnostic and Staging Procedure At Other Facility |
| LFSurDiaAndStagingProcExample |
Example of Surgical Diagnostic and Staging Procedure |
| LFSurMarDisOfPriSiteExample |
Example of Surgical Margins Distance Of The Primary Site |
| LFSurMarDisOfPriSiteExample-1 |
Example of Surgical Margins Distance Of The Primary Site |
| LFSurMarOfPriSiteExample |
Example of Surgical Margins Of The Primary Site |
| LFSurProcOfPriSiteAtOthFacExample |
Example of Surgical Procedure of Primary Site at Other Facility |
| LFSurProcOfPriSiteExample |
Example of Surgical Procedure of Primary Site |
| LFSurProcOthSiteAtOthFacExample |
Example of Surgical Procedure/Other Site at Other Facility |
| LFSurProcOthSiteExample |
Example of Surgical Procedure/Other Site |
| LFSysTherapyExample |
Example of Systemic Therapy |
| LFTarTherapyAtOthFacExample |
Example of Targeted Therapy At Other Facility |
| LFTarTherapyExample |
Example of Targeted Therapy |
| LFTumorSizeExample |
Example of Tumor Size |
| LFTumorSizeExample-1 |
Example of Tumor Size |
| LFWeightExample |
Example of Weight |
| 癌症登記長表 |
Example of Composition |